产前抗抑郁药暴露与子代大脑形态学轨迹
这项基于荷兰Generation R前瞻性队列的研究纳入3198对母子,分析产前SSRI暴露与母亲抑郁症状对子代7至15岁脑结构发育的关联。结果显示产前SSRI暴露与子代大脑灰质体积减少及杏仁核、梭状回体积随年龄增长更陡相关;产前抑郁与吻侧前扣带回体积较小相关,产后抑郁与梭状回体积减少相关。
要点
- 产前SSRI暴露与子代大脑灰质体积减少相关,尤其涉及皮质边缘回路,并持续至15岁。
- 产前SSRI暴露与杏仁核和梭状回体积在7至15岁间更陡增加相关,但童年期差异未持续至青春期早期。
- 产前抑郁与吻侧前扣带回体积较小相关,产后抑郁与梭状回体积减少相关。
核心结论
- 产前SSRI暴露可能与子代情绪调节相关脑区发育轨迹改变有关,需进一步研究其功能意义。
研究设计与样本
- 前瞻性、基于人群的队列研究,嵌套于荷兰鹿特丹Generation R研究,纳入3198对母子,子代在7至15岁接受3次脑MRI评估,共5624次扫描。
主要发现
- 产前SSRI暴露儿童杏仁核体积随年龄增长更陡(年龄交互:β[SE],43.3[13.4] mm3;P=.006),梭状回也如此(年龄交互:β[SE],168.3[51.4] mm3;P=.003)。
- 产前抑郁与吻侧前扣带回体积较小相关(β[SE],-166.3[65.1] mm3;P=.006),产后抑郁与梭状回体积减少相关(β[SE],-480.5[189.2] mm3;P=.002)。
- 孕前使用SSRI与脑结局无关联。
临床怎么用
- 临床决策孕期SSRI治疗时,应权衡产前SSRI暴露与母亲抑郁症状对子代脑发育的潜在关联,个体化评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Clinical decision-making on antidepressant treatment during pregnancy, particularly selective serotonin reuptake inhibitors (SSRIs), is challenging, as both prenatal SSRI exposure and maternal depressive symptoms may be associated with negative outcomes in offspring. OBJECTIVE: To investigate the association between intrauterine SSRI exposure and maternal depressive symptoms and structural brain development in offspring from mid-childhood to early puberty. DESIGN, SETTING, AND PARTICIPANTS: This prospective, population-based cohort study was embedded in the Generation R Study in Rotterdam, the Netherlands. All pregnant individuals with an expected delivery date between April 1, 2002, and January 31, 2006, were invited to participate. Data were analyzed from February 1 to September 30, 2022. EXPOSURE: Maternal-reported SSRI use verified by pharmacy records. In mid-pregnancy and 2 and 6 months after delivery, participants reported depressive symptoms using the Brief Symptom Inventory and were divided into 5 groups: SSRI use during pregnancy (n = 41; 80 scans), SSRI use only before pregnancy (n = 77; 126 scans), prenatal depressive symptoms without prenatal SSRI use (n = 257; 477 scans), postnatal depressive symptoms only (n = 74; 128 scans), and nonexposed control individuals (n = 2749; 4813 scans). MAIN OUTCOMES AND MEASURES: The main outcome was brain morphometry in offspring, including global and cortical brain volumes, measured at 3 magnetic resonance imaging assessments from 7 to 15 years of age. RESULTS: The study included 3198 mother-child dyads. A total of 3198 mothers (100%) identified as women; mean (SD) age at intake was 31.1 (4.7) years. Children (1670 [52.2%] female) underwent brain imaging assessment from 7 to 15 years of age with 5624 total scans. Most brain gray matter volumes showed an inverted U-shaped trajectory. Compared with nonexposed controls, children prenatally exposed to SSRIs had less cerebral gray matter (β [SE], -20 212.2 [7285.6] mm3; P = .006), particularly within the corticolimbic circuit, which persisted up to 15 years of age. Children exposed to SSRIs prenatally showed a steeper increase in volumes of the amygdala (age interaction: β [SE], 43.3 [13.4] mm3; P = .006) and fusiform gyrus (age interaction: β [SE], 168.3 [51.4] mm3; P = .003) from 7 to 15 years of age. These volumetric differences in the amygdala and fusiform observed in childhood did not persist until early adolescence. Prenatal depression was associated with a smaller volume in the rostral anterior cingulate gyrus (β [SE], -166.3 [65.1] mm3; P = .006), and postnatal depression was associated with a reduced fusiform gyrus (β [SE], -480.5 [189.2] mm3; P = .002). No association of SSRI use before pregnancy with brain outcomes was observed. CONCLUSIONS AND RELEVANCE: The results of this cohort study suggest that prenatal SSRI exposure may be associated with altered developmental trajectories of brain regions involved in emotional regulation in offspring. Further research on the functional implications of these findings is needed.
引用
- Koc D, Tiemeier H, Stricker BH, et al. Prenatal Antidepressant Exposure and Offspring Brain Morphologic Trajectory. JAMA Psychiatry. 2023. PMID: 37647036. doi:10.1001/jamapsychiatry.2023.3161
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。